Crohn s disease

Management of Crohn's disease.
[10582935] BMJ 319(7223): 1480-5 (1999)

Neurologic and neuropsychiatric complications of Crohn's disease.
[9191736] South Med J 90(6): 606-10 (1997)

Guidelines for treatment with infliximab for Crohn's disease.
[16929083] Neth J Med 64(7): 219-29 (2006)

Infliximab use in patients with Crohn's disease: quality of life, costs and resource use.
[16929082] Neth J Med 64(7): 212-8 (2006)

The Dutch guidelines for treatment with infliximab for Crohn's disease.
[16929081] Neth J Med 64(7): 210-1 (2006)

Adalimumab for the treatment of Crohn's disease.
[19707457] Biologics 2(4): 763-77 (2008)

Natalizumab in the treatment of Crohn's disease.
[19707360] Biologics 2(2): 275-84 (2008)

An evidence-based review of natalizumab therapy in the management of Crohn's disease.
[20011247] Ther Clin Risk Manag 5(-): 935-42 (2009)

Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease?
[19325887] PLoS Pathog 5(3): e1000234 (2009)

Crohn's disease caused by Mycobacterium avium subspecies paratuberculosis: a public health tragedy whose resolution is long overdue.
[11800469] J Med Microbiol 51(1): 3-6 (2002)

The role of mycobacteria in Crohn's disease.
[8046739] J Med Microbiol 41(2): 74-94 (1994)

Disappearance of Crohn's ulcers in the terminal ileum after thalidomide therapy.
[14997219] Can J Gastroenterol 18(2): 101-4 (2004)

Surgery for small bowel Crohn's disease: experience of a tertiary referral center.
[19861850] Saudi J Gastroenterol 11(2): 85-92 (2005)

Neutrophil expression and infiltration into Crohn's intestine.
[19861848] Saudi J Gastroenterol 11(2): 63-72 (2005)

Role of flagellin in Crohn's disease: emblematic of the progress and enigmas in understanding inflammatory bowel disease.
[19107795] Inflamm Bowel Dis 15(5): 789-95 (2009)

Postoperative therapy for Crohn's disease.
[18942739] Inflamm Bowel Dis 15(3): 463-72 (2009)

Intestinal dendritic cells and epithelial barrier dysfunction in Crohn's disease.
[18821596] Inflamm Bowel Dis 15(3): 436-53 (2009)

Positioning biologic agents in the treatment of Crohn's disease.
[19309716] Inflamm Bowel Dis 15(10): 1570-82 (2009)

A review of activity indices and end points for clinical trials in children with Crohn's disease.
[15677913] Inflamm Bowel Dis 11(2): 185-96 (2005)

Clinical characteristics of familial versus sporadic Crohn's disease using the Vienna Classification.
[15290912] Inflamm Bowel Dis 10(3): 201-6 (2004)

6-Mercaptopurine is effective in Crohn's disease without concomitant steroids.
[15168805] Inflamm Bowel Dis 10(2): 79-84 (2004)

Medical therapy for Crohn's disease strictures.
[15058528] Inflamm Bowel Dis 10(1): 55-60 (2004)

Management of internal fistulas in Crohn's disease.
[11854609] Inflamm Bowel Dis 8(2): 106-11 (2002)

Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease.
[11380040] Inflamm Bowel Dis 7 Suppl 1(-): S23-9 (2001)

Measles virus and Crohn's disease: a critical appraisal of the current literature.
[11233661] Inflamm Bowel Dis 7(1): 51-7 (2001)

Prevention of relapse of Crohn's disease.
[11149565] Inflamm Bowel Dis 6(4): 321-8; discussion 329 (2000)

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.
[10701144] Inflamm Bowel Dis 6(1): 8-15 (2000)

Immunotherapy of Crohn's disease.
[9705600] Mediators Inflamm 7(3): 149-52 (1998)

NOD2 and Crohn's disease: loss or gain of function?
[15963781] Immunity 22(6): 661-7 (2005)

Autoimmunity and apoptosis: the Crohn's connection.
[11485733] Immunity 15(1): 5-14 (2001)

The many faces of malnutrition in Crohn disease.
[9583836] Am J Clin Nutr 67(5): 819-20 (1998)

Anal lesions in Crohn's disease.
[2192671] Ann R Coll Surg Engl 72(3): 158-9 (1990)

Pathology of Crohn's disease.
[2192670] Ann R Coll Surg Engl 72(3): 150-1 (1990)

Incidence, diagnosis, and treatment of enteric and colorectal fistulae in patients with Crohn's disease.
[8239781] Ann Surg 218(5): 660-6 (1993)

Spontaneous free perforation and perforated abscess in 30 patients with Crohn's disease.
[3541802] Ann Surg 205(1): 72-6 (1987)

The long-term outcome of restorative operation in Crohn's disease: influence of location, prognostic factors and surgical guidelines.
[7114939] Ann Surg 196(3): 345-55 (1982)

Comparison of the results of resection, bypass, and bypass with exclusion for ileocecal Crohn's disease.
[646491] Ann Surg 187(5): 530-5 (1978)

Systematic review: nutritional therapy in paediatric Crohn's disease.
[18045244] Aliment Pharmacol Ther 27(4): 293-307 (2008)

Review article: the evidence base for interventions used to maintain remission in Crohn's disease.
[17919275] Aliment Pharmacol Ther 27(1): 11-8 (2008)

Systematic review: Endoscopic dilatation in Crohn's disease.
[17903236] Aliment Pharmacol Ther 26(11-12): 1457-64 (2007)

Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
[17877506] Aliment Pharmacol Ther 26(7): 987-1003 (2007)

Meta-analysis: enteral nutrition in active Crohn's disease in children.
[17767463] Aliment Pharmacol Ther 26(6): 795-806 (2007)

Review article: appropriate use of corticosteroids in Crohn's disease.
[17635367] Aliment Pharmacol Ther 26(3): 313-29 (2007)

Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn's disease.
[17539978] Aliment Pharmacol Ther 25(12): 1389-99 (2007)

Review article: the diagnosis and management of Crohn's disease in populations with high-risk rates for tuberculosis.
[17539977] Aliment Pharmacol Ther 25(12): 1373-88 (2007)

Meta-analysis: mortality in Crohn's disease.
[17402989] Aliment Pharmacol Ther 25(8): 861-70 (2007)

Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
[17229216] Aliment Pharmacol Ther 25(1): 3-12 (2007)

Systematic review: managing anaemia in Crohn's disease.
[17206940] Aliment Pharmacol Ther 24(11-12): 1507-23 (2006)

Review article: Medical therapy for fistulizing Crohn's disease.
[17059510] Aliment Pharmacol Ther 24(9): 1283-93 (2006)

Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease.
[16611269] Aliment Pharmacol Ther 23(8): 1097-104 (2006)

Polypharmacy and Crohn's disease.
[15882241] Aliment Pharmacol Ther 21(10): 1211-6 (2005)

Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease.
[15771759] Aliment Pharmacol Ther 21(6): 733-8 (2005)

Systematic review: has disease outcome in Crohn's disease changed during the last four decades?
[15339320] Aliment Pharmacol Ther 20(5): 483-96 (2004)

How effective are the usual treatments for Crohn's disease?
[15233694] Aliment Pharmacol Ther 20(2): 151-9 (2004)

Review article: The medical treatment of Crohn's perianal fistulas.
[15113362] Aliment Pharmacol Ther 19(9): 953-67 (2004)

Fistula response to methotrexate in Crohn's disease: a case series.
[14616166] Aliment Pharmacol Ther 18(10): 1003-8 (2003)

Review article: mild to moderate Crohn's disease--defining the basis for a new treatment algorithm.
[12895211] Aliment Pharmacol Ther 18(3): 263-77 (2003)

Review article: biological agents in the treatment of Crohn's disease.
[12197837] Aliment Pharmacol Ther 16(9): 1579-90 (2002)

The effectiveness of budesonide therapy for Crohn's disease.
[12182751] Aliment Pharmacol Ther 16(8): 1509-17 (2002)

Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?
[11966492] Aliment Pharmacol Ther 16(5): 857-67 (2002)

The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review.
[11856078] Aliment Pharmacol Ther 16(1): 51-60 (2002)

Review article: the immunoregulatory cytokine interleukin-10--a therapy for Crohn's disease?
[11683684] Aliment Pharmacol Ther 15(11): 1709-16 (2001)

Review article: the limitations of corticosteroid therapy in Crohn's disease.
[11563990] Aliment Pharmacol Ther 15(10): 1515-25 (2001)

Review article: the management of severe Crohn's disease.
[11328250] Aliment Pharmacol Ther 15(5): 563-73 (2001)

Budesonide in the treatment of Crohn's disease: a meta-analysis.
[11069312] Aliment Pharmacol Ther 14(11): 1419-28 (2000)

Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases.
[19832726] Aliment Pharmacol Ther 31(2): 189-201 (2010)

Meta-analysis: the efficacy and safety of certolizumab pegol in Crohn's disease.
[19183161] Aliment Pharmacol Ther 29(6): 605-14 (2009)

Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn's disease.
[18346185] Aliment Pharmacol Ther 27(12): 1210-23 (2008)

Review article: treatment of perianal fistulizing Crohn's disease.
[15352905] Aliment Pharmacol Ther 20 Suppl 4(-): 106-10 (2004)

Review article: indication and type of surgery in Crohn's disease.
[12047262] Aliment Pharmacol Ther 16 Suppl 4(-): 59-64 (2002)

Review article: Crohn's disease--the role of nutritional therapy.
[12047260] Aliment Pharmacol Ther 16 Suppl 4(-): 48-52 (2002)

Review article: the management of refractory Crohn's disease.
[12047259] Aliment Pharmacol Ther 16 Suppl 4(-): 40-7 (2002)

Review article: medical treatment of active Crohn's disease.
[12047258] Aliment Pharmacol Ther 16 Suppl 4(-): 35-9 (2002)

Review article: monitoring the activity of Crohn's disease.
[12047257] Aliment Pharmacol Ther 16 Suppl 4(-): 29-33 (2002)

Diagnosis and treatment of perianal fistulas in Crohn disease.
[11712881] Ann Intern Med 135(10): 906-18 (2001)

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
[16481630] Gut 55 Suppl 1(-): i36-58 (2006)

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.
[16481629] Gut 55 Suppl 1(-): i16-35 (2006)

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.
[16481628] Gut 55 Suppl 1(-): i1-15 (2006)

Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease.
[15917403] J Clin Pathol 58(6): 568-72 (2005)

Cross-sectional imaging in Crohn disease.
[15143222] Radiographics 24(3): 689-702 (2004)

Manifestations of Crohn disease at US.
[8897619] Radiographics 16(3): 499-520; discussion 520-1 (1996)

Crohn's disease: less common radiographic manifestations.
[3283867] Radiographics 8(2): 259-75 (1988)

MR enterographic manifestations of small bowel Crohn disease.
[20228323] Radiographics 30(2): 367-84 (2010)

Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy.
[16373764] Radiology 238(1): 128-34 (2006)

Role of US in detection of Crohn disease: meta-analysis.
[15987966] Radiology 236(1): 95-101 (2005)

Crohn disease: state of the art.
[9051003] Radiology 202(3): 597-610 (1997)

Inflammatory bowel disease. Part II: Crohn's disease--pathophysiology and conventional and alternative treatment options.
[15656711] Altern Med Rev 9(4): 360-401 (2004)

TLRs in the Gut. III. Immune responses to flagellin in Crohn's disease: good, bad, or irrelevant?
[17038626] Am J Physiol Gastrointest Liver Physiol 292(3): G706-10 (2007)

Magnetic resonance imaging in Crohn's disease.
[18245000] BMJ 336(7638): 273-6 (2008)

Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesis.
[21472099] World J Gastroenterol 17(11): 1416-26 (2011)

Current treatment of rectovaginal fistula in Crohn's disease.
[21448347] World J Gastroenterol 17(8): 963-7 (2011)

Defensins couple dysbiosis to primary immunodeficiency in Crohn's disease.
[21350705] World J Gastroenterol 17(5): 567-71 (2011)

Role of conventional therapies in the era of biological treatment in Crohn's disease.
[21528051] World J Gastroenterol 17(14): 1797-806 (2011)

Perianal Crohn's disease: is there something new?
[21528071] World J Gastroenterol 17(15): 1939-46 (2011)

Efficacy of early treatment with infliximab in pediatric Crohn's disease.
[20380012] World J Gastroenterol 16(14): 1776-81 (2010)

Crohn's disease--defect in innate defence.
[18810765] World J Gastroenterol 14(36): 5499-503 (2008)

Long-term antibiotic treatment for Crohn's disease: systematic review and meta-analysis of placebo-controlled trials.
[20067425] Clin Infect Dis 50(4): 473-80 (2010)

The role of microbes in Crohn's disease.
[17173227] Clin Infect Dis 44(2): 256-62 (2007)

Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review.
[20427501] J Clin Endocrinol Metab 95(7): 3111-7 (2010)

Viruses, autophagy genes, and Crohn's disease.
[21994779] Viruses 3(7): 1281-311 (2011)

Genotyping for NOD2 genetic variants and crohn disease: a metaanalysis.
[19713276] Clin Chem 55(11): 1950-7 (2009)

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.
[21291629] Health Technol Assess 15(6): 1-244 (2011)

Nutritional consequences and nutrition therapy in Crohn's disease.
[20117347] Gastroenterol Clin Biol 33 Suppl 3(-): S235-44 (2009)

Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: a meta-analysis.
[21912760] Can J Gastroenterol 25(9): 492-6 (2011)

The anti-Saccharomyces cerevisiae antibody assay in a province-wide practice: accurate in identifying cases of Crohn's disease and predicting inflammatory disease.
[16341311] Can J Gastroenterol 19(12): 717-21 (2005)

Frequency of epithelioid granulomas in colonoscopic biopsy specimens from paediatric and adult patients with Crohn's colitis.
[17293387] J Clin Pathol 60(11): 1268-72 (2007)

Clinical value of gene NOD2/CARD15 mutations in Crohn's disease.
[16266220] Rev Esp Enferm Dig 97(8): 541-6 (2005)

Methotrexate for maintenance of remission in chronic active Crohn's disease: long-term single-center experience and meta-analysis of observational studies.
[19924799] Inflamm Bowel Dis 16(7): 1195-202 (2010)

Surgical management of pyogenic complications of Crohn's disease.
[20049952] Inflamm Bowel Dis 16(3): 512-7 (2010)

Perianal fistulae in Crohn's Disease: current and future approaches to treatment.
[19834976] Inflamm Bowel Dis 16(5): 870-80 (2010)

Growth retardation in pediatric Crohn's disease: pathogenesis and interventions.
[17262806] Inflamm Bowel Dis 13(5): 620-8 (2007)

Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis.
[17886288] Inflamm Bowel Dis 14(3): 401-10 (2008)

Further experience with the use of 6-thioguanine in patients with Crohn's disease.
[18521912] Inflamm Bowel Dis 14(10): 1399-405 (2008)

In vivo single-photon emission computed tomography imaging of apoptosis in Crohn's disease and anti-tumour necrosis factor therapy.
[17369380] Gut 56(4): 461-3 (2007)

European evidence-based consensus on the diagnosis and management of Crohn's disease.
[17303600] Gut 56(2): 161-3 (2007)

Review of the safety and efficacy of ustekinumab.
[21180612] Therap Adv Gastroenterol 3(5): 321-8 (2010)

Optimal use of biologics in the management of Crohn's disease.
[21180600] Therap Adv Gastroenterol 3(3): 179-89 (2010)

Crohn's disease: a surgeon's perspective.
[21196646] Saudi J Gastroenterol 17(1): 6-15 (2011)

Crohn's disease: drug therapy or surgery?
[19072408] Expert Rev Gastroenterol Hepatol 1(2): 187-92 (2007)

Current and future role of biomarkers in Crohn's disease risk assessment and treatment.
[21753895] Clin Exp Gastroenterol 4(-): 127-40 (2011)

Update on the management of inflammatory bowel disease: specific role of adalimumab.
[21904462] Clin Exp Gastroenterol 4(-): 163-72 (2011)

Infliximab to treat Crohn's disease: an update.
[22016584] Clin Exp Gastroenterol 4(-): 227-38 (2011)

Infliximab therapy in pediatric Crohn's disease: a review.
[21694847] Clin Exp Gastroenterol 3(-): 57-63 (2010)

What is the most accurate method for the assessment of small bowel in involvement in Crohn's disease?
[20549886] Turk J Gastroenterol 21(1): 80-2 (2010)

What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?
[20552736] Turk J Gastroenterol 21(1): 107-12 (2010)

Revisiting Crohn's disease as a primary immunodeficiency of macrophages.
[19687225] J Exp Med 206(9): 1839-43 (2009)

Vitamin D, NOD2, autophagy and Crohn's disease.
[20594120] Expert Rev Clin Immunol 6(4): 505-8 (2010)

Paneth cell function--implications in pediatric Crohn disease.
[21637018] Gut Microbes 2(1): 47-51 (2011)

The endoplasmic reticulum stress response chaperone: Gp96, a host receptor for Crohn disease-associated adherent-invasive Escherichia coli.
[21637029] Gut Microbes 2(2): 115-9 (2011)

Role of Nod2 in the development of Crohn's disease.
[19573617] Microbes Infect 11(12): 912-8 (2009)

Maintenance treatment with infliximab for the management of Crohn's disease in adults.
[19707394] Biologics 3(-): 39-49 (2009)

Morbus Crohn--a disease of failing macroautophagy in the immune system?
[19762453] Int Immunol 21(11): 1205-11 (2009)

Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870).
[17722511] Int J Nanomedicine 2(1): 39-47 (2007)

Innate immune defence: NOD2 and autophagy in the pathogenesis of Crohn's disease.
[21213148] Swiss Med Wkly 140(): w13135 (2011)

Crohn's disease: NOD2, autophagy and ER stress converge.
[21252204] Gut 60(11):1580-8 (2011)

Pulmonary manifestations of Crohn's disease.
[24415866] World J Gastroenterol 20(1):133-41 (2014)

Surgery for luminal Crohn's disease.
[24415860] World J Gastroenterol 20(1):78-90 (2014)

Natural history and long-term clinical course of Crohn's disease.
[24415855] World J Gastroenterol 20(1):31-6 (2014)

Prevention of post-operative recurrence of Crohn's disease.
[24574791] World J Gastroenterol 20(5):1147-54 (2014)

Immunoglobulin therapy for refractory Crohn's disease.
[24587823] Therap Adv Gastroenterol 7(2):99-102 (2014)

Serum omentin-1 as a disease activity marker for Crohn's disease.
[24659847] Dis Markers 2014():162517 (2014)

Minimally invasive surgery in Crohn's disease.
[24713789] Ann Gastroenterol 24(4):276-279 (2011)

The role of autophagy in Crohn's disease.
[24710487] Cells 1(3):492-519 (2012)

Management of Crohn's disease in poor responders to adalimumab.
[24748811] Clin Exp Gastroenterol 7():83-92 (2014)

Environmental influences on the onset and clinical course of Crohn's disease-part 1: an overview of external risk factors.
[24764788] Gastroenterol Hepatol (N Y) 9(11):711-7 (2013)

Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use.
[24772046] Gastroenterol Hepatol (N Y) 9(12):803-10 (2013)

Crohn's disease: the subsequent visit.
[24707229] Gastroenterol Hepatol (N Y) 9(1):16-20 (2013)

Successful treatment of localized pyoderma faciale in a patient with Crohn's disease.
[24719607] Gastroenterol Hepatol (N Y) 9(8):541-3 (2013)

Capsule endoscopy in the small bowel Crohn's disease.
[24741374] Gastroenterol Res Pract 2014():529136 (2014)

Interleukin-19 impairment in active Crohn's disease patients.
[24718601] PLoS One 9(4):e93910 (2014)

Contrast-enhanced ultrasonography for the determination of Crohn's disease activity - preliminary experience.
[24723988] Pol J Radiol 79():70-4 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Crohn s disease.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Crohn s disease.php on line 92